BRPI0815460A2 - kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos - Google Patents

kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos

Info

Publication number
BRPI0815460A2
BRPI0815460A2 BRPI0815460A BRPI0815460A BRPI0815460A2 BR PI0815460 A2 BRPI0815460 A2 BR PI0815460A2 BR PI0815460 A BRPI0815460 A BR PI0815460A BR PI0815460 A BRPI0815460 A BR PI0815460A BR PI0815460 A2 BRPI0815460 A2 BR PI0815460A2
Authority
BR
Brazil
Prior art keywords
diagnostic kit
mammalian subjects
predicting cancer
genes
proteins
Prior art date
Application number
BRPI0815460A
Other languages
English (en)
Inventor
Haibe-Kains Benjamin
Desmedt Christine
Sotiriou Christos
Original Assignee
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bruxelles filed Critical Univ Bruxelles
Publication of BRPI0815460A2 publication Critical patent/BRPI0815460A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos". a presente invenção respeita a um conjunto de genes ou 5 proteínas consistindo em ou compreendendo pelo menos, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 10 possivelmente 100, 105, 110 genes ou proteínas ou o conjunto completo seleccionado a partir do quadro 10 e/ou do quadro 11 ou anticorpos (ou a porção hipervariável dos mesmos) dirigidos contra as proteínas codificadas por tais genes.
BRPI0815460A 2007-09-07 2008-09-05 kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos BRPI0815460A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97074307P 2007-09-07 2007-09-07
PCT/EP2008/061828 WO2009030770A2 (en) 2007-09-07 2008-09-05 Methods and tools for prognosis of cancer in er- patients

Publications (1)

Publication Number Publication Date
BRPI0815460A2 true BRPI0815460A2 (pt) 2019-02-26

Family

ID=40076838

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815460A BRPI0815460A2 (pt) 2007-09-07 2008-09-05 kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos

Country Status (7)

Country Link
US (1) US20100298160A1 (pt)
EP (1) EP2185728A2 (pt)
JP (1) JP2010537659A (pt)
AU (1) AU2008294687A1 (pt)
BR (1) BRPI0815460A2 (pt)
CA (1) CA2696947A1 (pt)
WO (1) WO2009030770A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275652A1 (en) * 2005-05-13 2008-11-06 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
WO2010118782A1 (en) 2009-04-17 2010-10-21 Universite Libre De Bruxelles Methods and tools for predicting the efficiency of anthracyclines in cancer
EP2270510A1 (en) * 2009-07-02 2011-01-05 EMBL (European Molecular Biology Laboratory) Diagnostic method for predicting the risk of cancer recurrence based on Histone macroH2A isoforms
US20140295416A1 (en) * 2010-12-06 2014-10-02 University Of Medicine And Dentistry Of New Jersey Novel Method of Cancer Diagnosis and Prognosis and Prediction of Response to Therapy
EP3103046B1 (en) * 2014-02-06 2020-03-25 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
JP7304030B2 (ja) * 2019-04-26 2023-07-06 国立大学法人 東京大学 がん治療の効果および予後の予測方法および治療手段の選択方法
EP4118431A1 (de) 2020-03-12 2023-01-18 Heinrich-Heine-Universität Düsseldorf Inhibition von fkbp1a zur therapie des triple-negativen mammakarzinoms
DE102020203224A1 (de) 2020-03-12 2021-09-16 Heinrich-Heine-Universität Düsseldorf Inhibition von FKBP1A zur Therapie des Triple-negativen Mammakarzinoms
CN113025716A (zh) * 2021-03-02 2021-06-25 北京大学第一医院 一种用于人肿瘤分级的基因组合及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0323225D0 (en) * 2003-10-03 2003-11-05 Ncc Technology Ventures Pte Lt Materials and methods relating to breast cancer classification
BRPI0515562A (pt) * 2004-09-22 2008-07-29 Tripath Imaging Inc métodos e composições para avaliação do prognóstico do cáncer de mama
CA2608643A1 (en) 2005-05-13 2006-11-16 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
US20080275652A1 (en) * 2005-05-13 2008-11-06 Universite Libre De Bruxelles Gene-based algorithmic cancer prognosis
US20070218512A1 (en) * 2006-02-28 2007-09-20 Alex Strongin Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management

Also Published As

Publication number Publication date
JP2010537659A (ja) 2010-12-09
US20100298160A1 (en) 2010-11-25
CA2696947A1 (en) 2009-03-12
AU2008294687A1 (en) 2009-03-12
EP2185728A2 (en) 2010-05-19
WO2009030770A2 (en) 2009-03-12
WO2009030770A3 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
BRPI0815460A2 (pt) kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos
EA200702278A1 (ru) Антитела, специфичные в отношении tgf-бета 1
IL258880A (en) Diarylhydantoin compounds
EP2001363A4 (en) SYSTEM, METHOD AND INSTRUMENTS FOR IMAGE-LEADED PROSTATE TREATMENT
BRPI0506726B8 (pt) anticorpo monoclonal específico para m-csf e usos deste
WO2007109236A3 (en) Microrna fingerprints during human megakaryocytopoiesis
EA200802213A1 (ru) Способы лечения заболеваний крови
UA109633C2 (uk) Антитіло людини проти тканинного фактора
MX2011006422A (es) Autoanticuerpos humanos anti-alfa-sinucleina.
UY31114A1 (es) Anticuerpos humanizados contra el globulómero ab(20-42) y sus usos
DK1629011T3 (da) Humane anti-humane-DC3-bindingsmolekyler
MX2010005022A (es) Anticuerpos que unen celulas dendriticas y epiteliales 205 (dec-205) humanas.
BRPI0613382A8 (pt) anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
BR122018069446B8 (pt) método in vitro para detectar a presença de um célula de câncer em um indivíduo
MX2008012754A (es) Composiciones de anticuerpos y metodos para tratamiento de enfermedad neoplastica.
AU2006226733A8 (en) Antibodies against CD38 for treatment of multiple myeloma
NZ704295A (en) Compositions and methods for the treatment of infections and tumors
EP1885399A4 (en) HUMANIZED ANTIBODIES TO CD40 AND METHOD FOR THEIR USE
WO2007016548A3 (en) Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
MX2008009886A (es) Anticuerpos que enlazan par-2.
MY145058A (en) Prlr-specific antibody and uses thereof
MX351889B (es) Composiciones y métodos anti-cxcr1.
MX2009005849A (es) Composiciones y metodos para tratar cancer con adn rico en cpg y cupredoxinas.
SG171598A1 (en) Blood group antigens of different types for diagnostic and therapeutic applications

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A, 8A, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2513 DE 06-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]